Cargando…
SF2312 is a natural phosphonate inhibitor of Enolase
Despite being critical for energy generation in most forms of life, few if any microbial antibiotics specifically inhibit glycolysis. To develop a specific inhibitor of the glycolytic enzyme Enolase 2 for the treatment of cancers with deletion of Enolase 1, we modeled the synthetic tool compound inh...
Autores principales: | Leonard, Paul G., Satani, Nikunj, Maxwell, David, Lin, Yu-Hsi, Hammoudi, Naima, Peng, Zhenghong, Pisaneschi, Federica, Link, Todd M., Lee, Gilbert R., Sun, Duoli, Prasad, Basvoju A. Bhanu, Di Francesco, Maria Emilia, Czako, Barbara, Asara, John M., Wang, Y. Alan, Bornmann, William, DePinho, Ronald A., Muller, Florian L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110371/ https://www.ncbi.nlm.nih.gov/pubmed/27723749 http://dx.doi.org/10.1038/nchembio.2195 |
Ejemplares similares
-
The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues
por: Pisaneschi, Federica, et al.
Publicado: (2019) -
An Enolase Inhibitor for the Targeted Treatment of ENO1-Deleted Cancers
por: Lin, Yu-Hsi, et al.
Publicado: (2020) -
Prodrugs of
a 1-Hydroxy-2-oxopiperidin-3-yl
Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers
por: Yan, Victoria C., et al.
Publicado: (2022) -
ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase
por: Satani, Nikunj, et al.
Publicado: (2016) -
Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate
por: Krucinska, Jolanta, et al.
Publicado: (2019)